Adaptive Biotechnologies Corp business relationships
Companies named in Adaptive Biotechnologies Corp’s 10-K filed 2026-02-26, and public companies whose annual reports name Adaptive Biotechnologies Corp. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 6.1 / 10
- AI naming
- 100 / 100 Top 1% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in Adaptive Biotechnologies Corp’s annual report 6
“Moreover, as our collaboration activities under the Microsoft Agreement have concluded, we may be less successful in pursuing these opportunities in the future.” SEC filing
“In the event Illumina ceases or slows its production of, or is otherwise unwilling or unable to continue to supply the sequencer reagents necessary for and currently used in our business at or near current pricing, we may be required to purchase different reagents from Illumina or to purchase from a...” SEC filing
“Because ASC 808 does not provide guidance on how to account for the activities under a collaborative arrangement, we applied the guidance in ASC Topic 606, Revenue from Contracts with Customers ( "ASC 606" ) to account for the activities related to the Genentech Agreement.” SEC filing
“We continued to exclude the commercial milestones and potential royalties from the transaction price, as those items related predominantly to the license rights granted to Genentech and would be assessed when and if such events occurred.” SEC filing
“On August 13, 2025, our worldwide collaboration and license agreement with Genentech, Inc. ("Genentech") (the "Genentech Agreement") was terminated, with termination effective February 9, 2026.” SEC filing
“Our Immune Medicine revenue consists of revenue generated from (1) providing sample testing services for our commercial research product, Adaptive Immunosequencing; (2) data licensing and target discovery services; and (3) our former collaboration with Genentech under the Genentech Agreement.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.